Difference between revisions of "Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8469)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Has Sectioning (P146): Bibliography (from DOI: 10.1038/s41392-020-0110-5) (Q10035), #quickstatements; #temporary_batch_1590236183485)
 
(25 intermediate revisions by the same user not shown)
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Competing interests (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Bibliography (from DOI: 10.1038/s41392-020-0110-5) / rank
 +
Normal rank

Latest revision as of 12:16, 23 May 2020

Publication: "Targeting cancer stem cell pathways for cancer therapy" published as Signal Transduct Target Ther; 2020 ; 5 8; DOI: 10.1038/s41392-020-0110-5
Language Label Description Also known as
English
Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
Publication: "Targeting cancer stem cell pathways for cancer therapy" published as Signal Transduct Target Ther; 2020 ; 5 8; DOI: 10.1038/s41392-020-0110-5

    Statements

    instance of
    Segment
    0 references
    Has Sectioning
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q8469&oldid=208101"